HotOtc Featured Company: Adolor Corporation (ADLR) Product in the Approvals Pipeline
Adolor Corporation, a biopharmaceutical company working in the pain management area, has one drug under FDA Phase I start-up study and one in final Phase II approvals consideration. “Promising” is the general word that most are currently using for the Phase II Entereg product. It is expecting further responses from the FDA on January 23d. A phase I Delta agonist product has been granted the go ahead for trials to begin in the first quarter of 2008. Currently, the short term prognosis for the Entereg product is thought to be good where approvals are concerned. Some, however, are a bit…